Bulk Quadrivalent Influenza Vaccine (split virion, inactivated)

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

Influenza virus haemagglutinin, Quantity: 30 microgram/mL

Pieejams no:

Seqirus Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Influenza virus haemagglutinin

Zāļu forma:

Injection, suspension

Kompozīcija:

Excipient Ingredients: dibasic sodium phosphate; water for injections; monobasic potassium phosphate; sodium chloride; potassium chloride; calcium chloride dihydrate; monobasic sodium phosphate

Ievadīšanas:

Intramuscular

Ārstēšanas norādes:

For active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

Produktu pārskats:

Visual Identification: Clear to slightly opaque liquid containing some sediment which readily resuspends upon shaking; Container Type: Bulk Container; Container Life Time: 10 Weeks; Container Temperature: Store at 2 to 8 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2016-08-03